Digital Digest | Jorge Palacios

Welcome to the Digital Health Digest series, hosted by Ellis Ward, Head of Digital Health. Join us in this Q&A series as we explore enlightening discussions with a wide range of individuals, including startup founders, investors, thought leaders, and influencers in the Digital Health field.

Interview with Jorge Palacios, Chief Science Officer at Bright Therapeutics

In this interview Head of Digital Health, Ellis Ward, sat down with Jorge Palacios, Chief Science Officer at Bright Therapeutics. Ellis and Jorge dive into some of the most pressing topics in the digital health space right now: Evidence Generation and Meaningful Metrics, Product Design vs Practical Needs, Balancing ROI vs Clinical Impact and Post-Launch Realities and Sustained Success. 

Dr. Palacios drives the research and scientific strategy for Bright Therapeutics, working on leading DTx products such as Recovery Record for eating disorders, Recovery Path for substance use disorders and Moodlinks for depression and anxiety disorders. 

Following his medical training and then PhD from King’s College London in Psychological Medicine, he helped shape and lead research and implementation of digital interventions at SilverCloud Health, through to its acquisition by Amwell. Jorge is a global advocate for digital therapeutics, his work has been featured in top academic journals, and he speaks widely at international conferences on expanding access and improving engagement with evidence-based digital interventions.

The interview is rounded off with Jorge’s predictions for what’s in store for the digital health industry in 2025 and beyond.